TCAR vs. TF-CAS
The objective of this study was to compare outcomes associated with Transcarotid Artery Revascularization and transfemoral carotid artery stenting using data from the VQI-TSP.
“Among patients undergoing treatment for carotid stenosis, transcarotid artery revascularization, compared with transfemoral carotid artery stenting, was significantly associated with a lower risk of stroke or death.”
JAMA. 2019 Dec 17;322(23):2313-2322
TCAR Vs. TF-CAS Results*
The investigators found a significant decrease in stroke and death for patients who underwent TCAR as well as procedural efficiencies such as less radiation and less contrast. The investigators also found a significant decrease in stroke or death at one year.
![TCAR_vs_TF-CAS_Bar_Data_1](https://silkroadmed.com/wp-content/uploads/2020/10/TCAR_vs_TF-CAS_Bar_Data_1.jpg)
![TCAR_vs_TF-CAS_Bar_Data_2](https://silkroadmed.com/wp-content/uploads/2020/10/TCAR_vs_TF-CAS_Bar_Data_2.jpg)
![TCAR_vs_TF-CAS_Bar_Data_3](https://silkroadmed.com/wp-content/uploads/2020/10/TCAR_vs_TF-CAS_Bar_Data_3.jpg)
*Study n=3,286
Related publications
![](https://silkroadmed.com/wp-content/uploads/2020/10/SRM_ClinicalResults_Publications_JAMA_620x397pxl.jpg)
Association of TCAR vs TF-CAS With Stroke or Death Among Patients With Carotid Artery Stenosis
Marc L. Schermerhorn et al
![](https://silkroadmed.com/wp-content/uploads/2020/10/SRM_ClinicalResults_Publications_CurrCardioReports_620x397pxl.jpg)
Learning Curve for Surgeons Adopting TCAR Based on the Vascular Quality Initiative...
Vikram S. Kashyap et al
![](https://silkroadmed.com/wp-content/uploads/2020/10/SRM_ClinicalResults_Publications_J_of_VascularSurgery_620x397pxl.jpg)
In-hospital Outcomes of TCAR and CEA in the Society for Vascular Surgery VQI
Marc L. Schermerhorn et al
![](https://silkroadmed.com/wp-content/uploads/2020/10/SRM_ClinicalResults_Publications_J_of_VascularSurgery_620x397pxl.jpg)
TCAR vs. transfemoral carotid artery stenting in the Society for Vascular Surgery VQI
Mahmoud B. Malas et al
Discover more clinical studies
![](https://silkroadmed.com/wp-content/uploads/2020/10/Frame-1-PROOF-Study.jpg)
First in man results using ENROUTE® Transcarotid Neuroprotection System.
![](https://silkroadmed.com/wp-content/uploads/2020/10/Frame-2-ROADSTER-Study.jpg)
Pre-Market Approval of the ENROUTE Neuroprotection System.
![](https://silkroadmed.com/wp-content/uploads/2020/10/Frame-3-ROADSTER-2-Study.jpg)
Post Approval registry validating safety and efficacy of the ENROUTE Stent.
![](https://silkroadmed.com/wp-content/uploads/2020/10/Frame-4-TCAR-Surveillance-Study.jpg)
Real world population data validating CEA-like outcomes.